ON THE THERAPY OF MALIGNANT THYROID TUMORS
Journal Article
·
· Aerztliche Forschung (West Germany) Discontinued
OSTI ID:4717744
The relative advantages of various radiation treatments (200-kv x rays, Co/sup 60/ gamma rays, high-speed electrons, radioiodine) are discussed and results of thyroid dosimetric neck structures were used to measure thyroid doses under various types of radiation. Isodose diagrams obtained with a water-filled Plexiglas phantom showed that 6000-r, ventrally directed, combined Co/sup 60/ and 17-Mev electron irradiation would be most effective delivering 60 to 90% of the surface dose to the gland. Under these conditions, vertebral bone marrow would receive only 10 to 20% of the superficial dose. I/sup 131/ treatment of thyroid tumors has the disadvantage of low incorporation in some types of tumors and the advantage that it is taken up by metastases as well as the primary tumor. In general, 100- to 150-mC oral doses of I/sup 131/ initially are recommended, to be followed 14 days later by a similar dose. The highest total dose given was 680 mC. Of patients given a single 120-mC dose of I/sup 131/, 44% showed a fall of circulating lymphocytes to a level 52% of the initiai value. Two weeks after a 240-mC dose, the level fell sharply, and in 6 to 8 weeks myxedema was noted. Total circulating leukocytes fell to approximates 30% of normal by 1 month after a 120-mC dose. Of 62 patients with thyroid tumors treated with I/sup 131/ and 200-kv x rays, only 18% were living after 1 yr. (H.H.D.)
- Research Organization:
- Universitat, Munich
- NSA Number:
- NSA-17-026966
- OSTI ID:
- 4717744
- Journal Information:
- Aerztliche Forschung (West Germany) Discontinued, Journal Name: Aerztliche Forschung (West Germany) Discontinued Vol. Vol: 17; ISSN ARZFA
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
ATTEMPT TO DETERMINE THE OPTIMAL DOSE IN THE RADIOTHERAPY OF HYPERTHYROID DISORDERS WITH I$sup 131$ CLINICAL RESULTS IN TREATED CASES
MYXEDEMA FOLLOWING RADIOACTIVE IODINE THERAPY OF HYPERTHYROIDISM
INDICATIONS, DOSAGES, AND EFFECTS OF THERAPY WITH INTERNAL USE OF RADIOIODINE, RADIOGOLD, AND RADIOPHOSPHORUS
Journal Article
·
Fri Feb 23 23:00:00 EST 1962
· Schweiz. Med. Wochschr.
·
OSTI ID:4776049
MYXEDEMA FOLLOWING RADIOACTIVE IODINE THERAPY OF HYPERTHYROIDISM
Journal Article
·
Fri Sep 01 00:00:00 EDT 1961
· American Journal of Medicine (U.S.)
·
OSTI ID:4750413
INDICATIONS, DOSAGES, AND EFFECTS OF THERAPY WITH INTERNAL USE OF RADIOIODINE, RADIOGOLD, AND RADIOPHOSPHORUS
Journal Article
·
Sun Dec 31 23:00:00 EST 1961
· Radiobiol. Radiotherap.
·
OSTI ID:4133328